Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

11151

1

ClearPoint Neuro, Inc. ClearPoint Neuro Reports 41% Revenue Growth, Improved Gross Profit in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11152

1

Axogen, Inc. Axogen Reports 17.9% Revenue Growth, Improved Financial Performance in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11153

1

HANCOCK WHITNEY CORP Hancock Whitney Reports Mixed Q3 Results with Increased Profitability and Challenges in Loan Growth and Credit Quality

Via official filing (AI summary) | 7 months ago | 0 comments

11154

1

Dutch Bros Inc. Dutch Bros Reports 27.9% Revenue Growth and 62.1% Net Income Increase in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11155

1

OneStream, Inc. OneStream Reports 21% Revenue Growth, Net Loss Widens in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11156

1

A.K.A. BRANDS HOLDING CORP. a.k.a. Brands Holding Corp. Reports Improved Financial Performance in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11157

1

Evoke Pharma Inc Evoke Pharma Reports Improved Financials, Increased Cash and Cash Equivalents, and Growing Net Product Sales

Via official filing (AI summary) | 7 months ago | 0 comments

11158

1

MID PENN BANCORP INC Mid Penn Bancorp Reports 33% Increase in Net Income, 4.5% Growth in Total Assets for Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11159

1

Oscar Health, Inc. Oscar Health Reports 70% Revenue Growth, Net Income Recovery in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11160

1

Lucid Group, Inc. Lucid Group Reports Decline in Revenue and Increased Net Losses in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11161

1

FLOTEK INDUSTRIES INC/CN/ Flotek Industries Reports Mixed Q3 Results, Net Income Up 92% Despite Revenue Decline

Via official filing (AI summary) | 7 months ago | 0 comments

11162

1

Poseida Therapeutics, Inc. Poseida Therapeutics Reports Significant Revenue Growth, Improved Operational Efficiency in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11163

1

Rallybio Corp Rallybio Reports Reduced Losses, Increased Revenue in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11164

1

AVITA Medical, Inc. AVITA Medical Reports 43.2% Revenue Growth, Widened Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11165

1

Nerdy Inc. Nerdy Inc. Reports Mixed Q3 and 9-Month Financial Results, Revenue Down 7% in Q3 but Up 3% for 9 Months

Via official filing (AI summary) | 7 months ago | 0 comments

11166

1

RCM TECHNOLOGIES, INC. RCM Technologies Reports Mixed Financial Results, Revenue Growth, and Strategic Developments

Via official filing (AI summary) | 7 months ago | 0 comments

11167

1

Target Group Inc. Target Group Inc. Reports Decline in Revenue and Assets, Raises Concerns About Going Concern

Via official filing (AI summary) | 7 months ago | 0 comments

11168

1

MACERICH CO Macerich Reports Improved Revenue and Profitability in Q3 2024, Net Income Turnaround

Via official filing (AI summary) | 7 months ago | 0 comments

11169

1

Doximity, Inc. Doximity Reports 20% Revenue Growth, Strong Operational Performance in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11170

1

StepStone Group Inc. StepStone Group Reports 42% Revenue Growth, Net Income Decline in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11171

1

Skye Bioscience, Inc. Skye Bioscience Reports Significant Financial Developments, Commences Phase 2 Clinical Trial for Lead Drug Candidate

Via official filing (AI summary) | 7 months ago | 0 comments

11172

1

MCKESSON CORP Mckesson Reports 21% Revenue Growth, Decline in Profitability Amid Increased Expenses and Restructuring Efforts

Via official filing (AI summary) | 7 months ago | 0 comments

11173

1

MANNKIND CORP MannKind Corporation Reports 37% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11174

1

BRUKER CORP Bruker Corporation Reports 16.4% Revenue Growth, Decline in Profitability in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11175

1

Axonics, Inc. Axonics Reports 24.8% Revenue Growth, Narrowed Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments